0001179022-19-000036.txt : 20190603
0001179022-19-000036.hdr.sgml : 20190603
20190603174219
ACCESSION NUMBER: 0001179022-19-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190531
FILED AS OF DATE: 20190603
DATE AS OF CHANGE: 20190603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ELDRED KARY
CENTRAL INDEX KEY: 0001543425
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 19874516
MAIL ADDRESS:
STREET 1: 2121 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-05-31
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001543425
ELDRED KARY
C/O GALECTIN THERAPEUTICS, INC.
4960 PEACHTREE INDUSTRIAL BLVD., STE 240
NORCROSS
GA
30071
1
0
0
0
Common Stock
2019-05-31
4
P
0
3033
4.28
A
44415
D
Common Stock
2425
I
as UTMA custodian for minor child
Common Stock
2000
I
held in trust
Common Stock Purchase Warrant (right to buy)
7.00
2019-05-31
4
P
0
10110
0
A
2019-11-30
2026-05-31
Common stock
758
10110
D
These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose.
These shares are held in a special needs trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Each warrant is exerciseable for 0.075 shares of Common Stock of the Company.
/s/ Jack W. Callicutt, by power of attorney
2019-06-03